로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
장바구니가 비어 있습니다
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > 녹아웃 세포주
녹아웃 세포주
소개
유전자 녹아웃 세포주는 유전자 편집 기술을 이용하여 특정 유전자가 완전히 제거되어, 유전자 기능, 질병 메커니즘, 약물 효능 및 맞춤형 의학을 연구에 사용됩니다.
유전자 편집 기술 중 하나인 CRISPR-Cas9는 매우 효율적이고 정밀하게 표적 유전체를 변형시킬 수 있습니다. 표적 유전자에 특이적으로 결합하는 가이드 RNA(gRNA)를 설계함으로써, CRISPR-Cas9는 Cas9 뉴클레아제를 정확한 유전체 위치로 이동시키고, 그곳에서 이중 가닥 DNA 절단을 유도합니다. 이후 세포는 비상동 말단 연결(NHEJ) 경로를 통해 절단을 복구하여, 이 과정에서 삽입 또는 결실(Indels)이 자주 발생합니다. 이러한 돌연변이는 일반적으로 리딩 프레임을 이동시켜 내재 유전체 수준에서 표적 유전자를 효과적으로 녹아웃시킵니다.
ACROBiosystems는 정교하고 효율적인 CRISPR-Cas9 유전자 편집 플랫폼을 이용하여 sgRNA 설계 및 검증, 유전자 편집 세포주의 구축부터 유전체 시퀀싱을 포함한 종합적인 워크플로우를 제공합니다. 혁신과 품질에 대한 지속적인 현신을 바탕으로 ACROBiosystems는 기능성과 안정성이 엄격하게 검증된 고품질 유전자 녹아웃 세포주를 지속적으로 개발하고 있습니다. 신뢰할 수 있는 세포 기반 연구 툴은 세포 수준에서 정밀하고 확신할 수 있는 연구를 지원하여 약물 발굴 및 개발을 촉진할 것입니다.
응용 시나리오

유전자 기능 연구 [1]

유전자 기능 연구

표적 및 신호전달 연구

표적 및 신호전달 연구

질병 메커니즘 연구 [2]

질병 메커니즘 연구

분자 표적 약물 연구 [3]

분자 표적 약물 연구

약물 발굴 및 스크리닝

약물 발굴 및 스크리닝

약물 안전성 평가

약물 안전성 평가

제품 특징

발현 분석(FACS) 및 게놈 시퀀싱을 통해 검증되어 유전자 녹아웃의 정확성과 신뢰성을 보장합니다.

유전자 변형 세포주는 MOA(작용 메커니즘)를 가장 잘 반영합니다.

강력하고 재현 가능한 세포 기반 바이오 분석을 위해 더 높은 활성과 더 큰 분석 창을 제공합니다.

분석 개발 및 검증을 지원하는 포괄적인 애플리케이션 데이터.

추적 가능한 전체 기록, 엄격한 품질 관리, 검증된 세포 통과 안정성.

국제적으로 공인된 세포 자원 은행에서 합법적으로 획득하고 상업적으로 허가된 모세포주입니다.

규제 신고가 필요할 때마다 글로벌 상업용 라이선스 지원.

로드맵

RNP 방식 (매우 낮은 비표적 효과, 유전자 삽입 위험성 제거, 높은 편집 효율)Recommended

RNP method

렌티바이러스 방식(높은 형질전환 효울, 장기적으로 안정적인 발현)

Lentiviral method
Contact usACROBiosystems의 검증된 CRISPR-Cas9 유전자 편집 플랫폼을 기반으로,Contact usContact us연구와 약물 개발을 위한 특정 표적 맞춤형 유전자 녹아웃
제품 리스트
  • ADC Targeting & CAR-T Cell Therapy

MoleculeCat. No.Product DescriptionOrder/Pre-order
CD19SCRAJ-STT216Raji/Human CD19 Knockout Stable Cell Line Development Service

Order

세포주 관련 서비스

세포주 관련 서비스
기능성 세포주 라이선싱 지원 서비스
FAQ

1. Are ACRO's cell line products monoclonal or cell pools?

All of our cell line products are monoclonal cell lines.

2. Can you provide vector information such as the vector map or the full sequence used for cell line generation?

According to our current company policy:

- With a signed Non-Disclosure Agreement (NDA), we are authorized to share the vector map.

- Without a signed NDA: We may disclose the sequence of the overexpressed target gene. Additionally, we can provide lentiviral residual testing reports upon request.

The following confidential information is not disclosed:

1. The complete vector sequence and the original vector name.

2. Sequences of signal response elements related to signal transduction pathways.

3. What are the shipping conditions for cell lines, and what should be noted upon receipt for storage and use?

Cell lines are shipped on dry ice. To ensure optimal cell viability, we recommend thawing and initiating culture immediately upon receipt. If immediate thawing and culturing are not possible, we advise transferring the cells to liquid nitrogen for long-term storage. Please ensure the transfer process is quick to avoid thawing, as this may impact the long-term stability and viability of the cells.

If immediate transfer to liquid nitrogen is not feasible, the cells can be temporarily stored in a -80°C freezer. However, we recommend that the storage period from the date of receipt should not exceed two weeks. Long-term storage on dry ice or in a -80°C freezer is not recommended.

When using the cells, please refer to the recommended thawing and culturing methods provided in the DS.

Please Note: If the cells are received unfrozen or not on dry ice, please contact our technical support team immediately at techsupport@acrobiosystems.com.

4. Why did I receive two cryovials of cell lines after purchasing a cell line product?

We provide two cryovials of cell lines to ensure the smooth progress of your experiments. In the event of any issues with thawing, recovery, or culturing of the first vial, please contact our technical support team (techsupport@acrobiosystems.com) for troubleshooting before thawing the second vial.

All ACRO cell lines undergo pre-shipment validation for recovery and culturing. Additionally, we recommend establishing a cell bank at the earliest possible passage stage to ensure long-term use.

5. What should be noted when recovering cell lines upon receipt?

After thawing the cells, they should initially be cultured in a medium without selection antibiotics for 1-2 passages. If the cells exhibit good condition, you can switch to a medium with selection antibiotics for further passaging. For guidance on selecting appropriate antibiotics, please refer to FAQ12.

Additionally, we recommend adding P/S (Penicillin-Streptomycin) to the culture medium throughout the entire cell culture process to maintain aseptic conditions.

6. What should be noted during cell passaging?

For Adherent Cells (e.g., HEK293):

Confluence: Avoid over-confluence during culture. If the confluence is too high (exceeding 100%), it may significantly affect cell viability after passaging. Please refer to the passaging methods and precautions in the  DS for specific instructions.

Post-Passaging Issues If cells exhibit poor adherence after passaging due to over-confluence or other reasons, we recommend:

- Removing selection antibiotics from the culture medium.

- Passaging at a higher cell density (e.g., 1×107 cells per T75 flask).

- Resuming normal passaging only after cell viability has recovered.

For Suspension Cells (e.g., Jurkat and Raji):

Cell Density: Avoid excessively high cell density. If the density is too high (exceeding 3×106cells/mL), it may significantly affect cell viability after passaging. Please refer to the passaging methods and precautions in the DS for specific instructions.

Post-Passaging Issues: If cells exhibit poor viability after passaging due to high density or other reasons, we recommend:

- Removing selection antibiotics from the culture medium.

- Passaging at a lower density (e.g., 1×105-2×105 cells/mL).

- Resuming normal passaging only after cell viability has recovered.

Always monitor cell health and adjust protocols as needed to maintain optimal growth conditions.

7. What type of culture plate is recommended for seeding adherent cells during initial functional experiments?

We recommend starting with a transparent 96-well plate for cell seeding (refer to the specific experimental protocol for details). This allows for easy observation of cell status and determination of whether the cell density is appropriate. Once the experimental conditions are optimized, you can transition to other suitable culture plates.

For recommended cell seeding densities, please refer to FAQ9.

For a list of commonly used culture plates and consumables, see the product experimental protocol.

8. Is it necessary to add selection antibiotics to the culture medium when seeding cells for functional experiments?

No, it is not necessary to add selection antibiotics.

9. What is the recommended cell seeding density for adherent cells in functional experiments?

For 96-well plates, we recommend seeding cells such that they reach approximately 80% confluence after overnight culture before conducting functional experiments. You can start by following the cell seeding density recommended in the ACRO experimental protocol or by testing a gradient of different cell densities to determine the optimal conditions for your experimental system.

10. Can I directly use the protein or drug concentrations recommended by ACRO in functional experiments?

During the initial stages of functional experiments, you can start by testing the protein or drug concentrations recommended by ACRO. However, due to variations in reagents or experimental conditions, we recommend conducting preliminary optimization experiments to determine the optimal concentration best suited for your specific experimental system.

11. Can I use culture media and serum from other manufacturers for cell culture?

We recommend prioritizing the use of culture media and serum from the manufacturers specified in the DS. However, you may also choose to use comparable alternatives or other suitable culture media and serum (e.g., Gibco) for testing and cultivation.

12. Can I use selection antibiotics from other manufacturers?

For selection antibiotics, we highly recommend using the brands specified in the DS. The activity of antibiotics may vary between manufacturers, so if you choose to use a different brand, it is essential to validate whether the concentration recommended in the ACRO culture protocol is suitable.

Regardless of the brand used, we recommend maintaining a backup culture without selection antibiotics to avoid potential cell loss due to inappropriate antibiotic concentration.

13. Can I use proteins from other manufacturers for functional activity experiments?

We highly recommend using the protein reagents from the manufacturers specified in the experimental protocol, as their activity has been validated by us. If you choose to use protein products from other manufacturers, we recommend conducting a concentration optimization based on the recommended concentrations in the protocol to identify the appropriate concentration for your experiments.

14. What do you recommend for cell freezing medium?

For both adherent and suspension cells, we recommend using 90% FBS + 10% DMSO (V/V) as the freezing medium. Alternatively, you may choose commercial cell freezing media or other suitable freezing media commonly used in your laboratory.

Recommended freezing density: 5×106 - 1×107cells/mL.

참고자료

[1]. Nieuwe methode om regulatie van genen in individuele cellen te bestuderen. Hubrecht Institute. Published 2019 Jun 17.

[2]. Plundrich D, Chikhladze S, Fichtner-Feigl S, Feuerstein R, Briquez PS. Molecular Mechanisms of Tumor Immunomodulation in the Microenvironment of Colorectal Cancer. Int J Mol Sci. 2022;23(5):2782. Published 2022 Mar 3. doi:10.3390/ijms23052782

[3]. Zhang DKY, Cheung AS, Mooney DJ. Activation and expansion of human T cells using artificial antigen-presenting cell scaffolds. Nat Protoc. 2020;15(3):773-798. doi:10.1038/s41596-019-0249-0

ACRO Quality

This web search service is supported by Google Inc.

totop